IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 86 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $685,774 | -7.1% | 112,238 | -2.8% | 0.02% | -21.4% |
| Q4 2022 | $738,211 | +1.0% | 115,526 | +50.8% | 0.03% | +16.7% |
| Q3 2022 | $731,000 | -21.7% | 76,629 | -9.5% | 0.02% | -14.3% |
| Q2 2022 | $934,000 | -12.6% | 84,639 | +31.8% | 0.03% | 0.0% |
| Q1 2022 | $1,069,000 | +4.4% | 64,205 | +19.6% | 0.03% | +3.7% |
| Q4 2021 | $1,024,000 | -34.1% | 53,665 | -14.8% | 0.03% | -42.6% |
| Q3 2021 | $1,553,000 | -11.6% | 62,985 | -6.7% | 0.05% | -11.3% |
| Q2 2021 | $1,756,000 | +68.0% | 67,485 | +104.5% | 0.05% | +51.4% |
| Q1 2021 | $1,045,000 | -31.8% | 33,008 | 0.0% | 0.04% | -43.5% |
| Q4 2020 | $1,532,000 | +10.9% | 33,008 | -21.4% | 0.06% | -10.1% |
| Q3 2020 | $1,382,000 | +4.8% | 41,989 | -12.7% | 0.07% | 0.0% |
| Q2 2020 | $1,319,000 | -26.1% | 48,076 | -19.5% | 0.07% | -41.0% |
| Q1 2020 | $1,786,000 | +5.1% | 59,687 | -2.8% | 0.12% | +11.4% |
| Q4 2019 | $1,700,000 | +28.1% | 61,423 | -15.8% | 0.10% | -9.5% |
| Q3 2019 | $1,327,000 | -27.8% | 72,917 | -2.8% | 0.12% | -21.6% |
| Q2 2019 | $1,839,000 | +23.6% | 75,000 | -52.1% | 0.15% | +85.0% |
| Q1 2019 | $1,488,000 | +4.0% | 156,495 | -3.2% | 0.08% | 0.0% |
| Q4 2018 | $1,431,000 | -29.1% | 161,657 | -9.9% | 0.08% | +1.3% |
| Q3 2018 | $2,019,000 | -18.0% | 179,479 | -6.7% | 0.08% | -18.6% |
| Q2 2018 | $2,463,000 | -20.6% | 192,419 | -8.5% | 0.10% | -23.0% |
| Q1 2018 | $3,102,000 | +153.0% | 210,330 | +37.3% | 0.13% | +129.1% |
| Q4 2017 | $1,226,000 | -14.8% | 153,194 | -17.5% | 0.06% | -29.5% |
| Q3 2017 | $1,439,000 | +5.5% | 185,628 | 0.0% | 0.08% | -31.0% |
| Q2 2017 | $1,364,000 | – | 185,628 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |